• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Lipid profiles of US youth improving over last two decades

byJason Nam, MDandDaniel Fisher
May 22, 2019
in Cardiology, Chronic Disease, Pediatrics, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this serial, cross-sectional analysis, US youths had improved triglycerides, LDL, HDL, and total cholesterol from 1999 to 2016.

2. While half of all US youths had ideal lipid levels, nearly a quarter had at least one unfavorable lipid measure.

Evidence Rating Level: 2 (Good)

Study Rundown: Optimal lipid levels help define cardiovascular health in childhood, and data on lipid levels for US youths can provide key insight into current and future cardiovascular health. While public health efforts have targeted improving overall nutrition for youths, there has not been a study to address trends in the prevalence of ideal levels for lipids and apolipoprotein B. In this serial, cross-sectional analysis, US youth had improved triglycerides, LDL, HDL, and total cholesterol from 1999 to 2016. While half of all US youths had ideal lipid levels, nearly a quarter had at least one unfavorable lipid measure.

While the results shows favorable trends for lipids and apolipoprotein B in US youth, the study has several limitations. For example, blood was drawn in the non-fasting state for adolescents. Also, youths taking lipid lowering medications were not excluded, thus making it even more difficult to attribute the improvement in lipid measures to non-pharmacological interventions. Still, this is an encouraging study overall and suggests that further improvements in US pediatric health may be achieved with concerted public health efforts.

Click to read the study in JAMA

RELATED REPORTS

150 minutes of moderate-to-vigorous physical activity per week may reduce cardiovascular risk in overweight or obese adults

2 Minute Medicine Rewind February 23, 2026

Sleeve gastrectomy may produce greater and more durable weight loss than semaglutide in patients with obesity

Relevant Reading: Ethnic Differences in Lipid Profiles of Overweight, Obese, and Severely Obese Children and Adolescents 6-19 Years of Age.

In-Depth [cross-sectional study]: 26,047 US youths aged 6 to 10 years who attended any exam during any National Health and Nutrition Examination Survey (NHANES) from 1999-2000 to 2015-2016 were used in this cross-sectional study. NHANES uses a complex, multistage probability sampling design to select a representative sample of the civilian noninstitutionalized US population. NHANES utilizes in-home interviews with mobile examinations and laboratory tests, including HDL and total cholesterol in youths aged 6 to 19 years and fasting triglycerides and apolipoprotein B in a subset of adolescents aged 12 to 19 years. Levels of lipids and apolipoprotein B were classified as ideal, borderline, or adverse according to the most recent pediatric lipid guidelines. In all youths, total cholesterol levels decreased linearly during the 18-year period from 164mg/dL (CI95 161 to 167mg/dL) in 1999-2000 to 155mg/dL (CI95 154 to 157 mg/dL) in 2015-2016 (β −0.6 mg/dL; CI95, -0.7 to -0.4 mg/dL per year). The proportion of youths with at least 1 adverse level of HDL, non-HDL, or total cholesterol decreased significantly for all youths from 23.1% to 19.2% (p = 0.002) and for children from 22.2% to 15.2% (p < 0.001), but not for adolescents (23.7% to 21.8%; p = .27). Secondary analyses were done for race/ethnicity and BMI. In these exploratory analyses, temporal trends in mean levels and in the prevalence of ideal and adverse levels were generally consistent across racial/ethnic groups and BMI categories. However, these trends were variable in magnitude and whether statistical significance was reached.

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: adolescent healthHDLLDLlipid panelobesitytriglycerides
Previous Post

Early myocardial infarction and familial hypercholesterolemia

Next Post

The SOLAR-1 trial: alpelisib prolongs progression free survival in PIK3CA-mutated, HR-positive, HER2-negative breast cancer patients

RelatedReports

Many new pediatric asthma cases attributable to obesity
Cardiology

150 minutes of moderate-to-vigorous physical activity per week may reduce cardiovascular risk in overweight or obese adults

February 26, 2026
Many new pediatric asthma cases attributable to obesity
Weekly Rewinds

2 Minute Medicine Rewind February 23, 2026

February 23, 2026
Many new pediatric asthma cases attributable to obesity
Chronic Disease

Sleeve gastrectomy may produce greater and more durable weight loss than semaglutide in patients with obesity

January 30, 2026
Tramadol use linked with increased risk of hypoglycemia hospitalizations
Cardiology

Oral semaglutide reshapes everyday obesity visits

February 3, 2026
Next Post
Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

The SOLAR-1 trial: alpelisib prolongs progression free survival in PIK3CA-mutated, HR-positive, HER2-negative breast cancer patients

Development of a risk index for colorectal cancer screening

Quick Take: Body composition and cardiovascular events in patients with colorectal cancer

Little variation seen in readmission rates between primary care physicians in Texas

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Adults with attention-deficit/hyperactivity disorder are at higher risk of poor long-term adherence to antihypertensive therapy
  • 150 minutes of moderate-to-vigorous physical activity per week may reduce cardiovascular risk in overweight or obese adults
  • 2 Minute Medicine: Pharma Roundup – Merck and Mayo Clinic’s AI precision medicine lab, Novartis’ remibrutinib hits Phase III hive endpoint, FDA grants priority review for iberdomide in myeloma, oral infigratinib boosts growth velocity in achondroplasia, and shingles vaccine/sildenafil linked to lower Alzheimer’s risk [February 2026]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.